Collaboration to Rapidly Scale AI-Powered Diabetic Retinopathy Testing Nationwide
CORALVILLE, IOWA November 26, 2024. Digital Diagnostics announced that it will expand the ability to quickly scale its diabetic retinopathy testing service in the Kingdom of Saudi Arabia in collaboration with Google Cloud. With more than eight million people living with diabetes in the Kingdom of Saudi Arabia, this population has an acute need for LumineticsCore, which is Digital Diagnostics’ AI solution that detects diabetic retinopathy at the point-of-care.
“Digital Diagnostics collaborating with Google Cloud enhances the ability for LumineticsCore [previously IDx-DR] to reach more patients living with diabetes who are most in need of specialty eye care,” said Digital Diagnostics CEO, John Bertrand. “By leveraging Google Cloud’s secure infrastructure, Digital Diagnostics will protect sensitive health data within national borders, safeguarding patient privacy, maintaining regulatory compliance, and fostering trust.”
Google Cloud will support the efficient and secure deployment and delivery of the LumineticsCore AI diagnostics solution. Digital Diagnostics will integrate Google Cloud’s regional Graphics Processing Units (GPUs) to support AI and machine learning more efficiently than Central Processing Units (CPUs). Through Google Cloud’s Partner Services Funds, Google Cloud is funding Evonence, a Google Cloud Premier Partner, to expand LumineticsCore compatibility to run on Google Cloud.
Digital Diagnostics’ collaboration with Google Cloud is the next milestone in the company’s years-long work to extend large-scale diabetic retinopathy testing to people living with diabetes in the Kingdom of Saudi Arabia. In 2022, Digital Diagnostics signed a memorandum of understanding with Saudi Arabia’s Ministry of Investment to explore potential collaborations around medical services, medical technology, and digital health. The following year, Digital Diagnostics announced a strategic partnership with Tamer Healthcare, an integrated healthcare and wellness firm that has served Saudi patients for more than 100 years, with the goal of making the healthcare system more comprehensive, effective, and integrated than ever before.
The collaboration with Google Cloud, launched November 2024 and has the potential to expand into other regional markets in the future. For additional details about LumineticsCore, visit https://www.digitaldiagnostics.com/products/eye-disease/lumineticscore/.
About Digital Diagnostics Inc.
Digital Diagnostics Inc. is a pioneering AI diagnostics company on a mission to transform the quality, accessibility, equity, and affordability of global healthcare through the application of technology in the medical diagnosis and treatment process. The company, originally founded by Michael Abramoff, MD, PhD, a neuroscientist, practicing fellowship-trained retina specialist, and computer engineer, is led by him and co-founder and CEO, John Bertrand.
Digital Diagnostics is paving the way for autonomous and assistive AI technology that is free of bias to become a new standard of care, contributing to democratizing healthcare and closing care gaps. The company works closely with patient advocacy groups, provider organizations, regulators, and other quality of care and ethics-focused stakeholders to enable the adoption of healthcare AI. For more information and the latest news follow: https://digitaldiagnostics.com/